Developing novel medicines FOR SEVERE IMMUNE SYSTEM DISORDERS
Recent News : JATT Acquisition Corp. and Zura Bio Limited Announce Definitive Business Combination Agreement to Create NYSE Listed Biotechnology Company | June 17, 2022
New Site Coming Soon
COPYRIGHT © 2022 ZURABIO
ALL RIGHTS RESERVED